---
title: "Canakinumab"
ocid: "ocds-h6vhtk-0553ef"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0553ef"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0553ef.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0553ef.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NORTHERN HEALTH AND SOCIAL CARE TRUST"
published: "2025-09-03"
---

# Canakinumab

Buyer: NORTHERN HEALTH AND SOCIAL CARE TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-0553ef

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0553ef)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0553ef.json)

## Summary

The Northern Health and Social Care Trust has entered into a contract for the supply of Canakinumab, a pharmaceutical product, in a procurement process classified under public authority - central government, with applicability under Northern Irish devolved regulations. This procurement process, located in Antrim, Northern Ireland, is complete at the award stage. The contract commenced on 19 August 2025 and is set to run until 31 May 2028, with the supplier identified as NOVARTIS PHARMACEUTICALS UK LIMITED. The procurement method employed was a direct award, justified by the supplier's exclusive intellectual property rights, which precludes competition.

This tender opportunity, while specific in its requirements due to patent constraints, offers robust business growth avenues for large pharmaceutical companies with a substantial focus on innovative drug development. It underscores the importance of holding exclusive rights and patents in the pharmaceutical industry, providing those organisations with monopoly-like conditions for offering specialised products like Canakinumab. Businesses seeking to participate in future tenders of this nature should focus on developing or acquiring exclusive intellectual property rights to remain competitive. Additionally, pharmaceutical companies should anticipate opportunities where exclusivity due to intellectual property rights could be leveraged in direct award scenarios, potentially expanding their market share through strategic patent acquisitions.

## Notice

The intended contract is for the supply of Canakinumab to Northern Health and Social Care Trust for up to a maximum of 3 years

### Procurement Information

Purchase of drugs which are subject to patent protection/Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/053420-2025 |
| Notice type | UK7 - Contract Details Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Sep 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 26 Jun 2025 |
| Contract period | 18 Aug 2025 - 31 May 2028 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £120,000 |
| Contracts value | £120,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NORTHERN HEALTH AND SOCIAL CARE TRUST |
| Locality | ANTRIM |
| Post town | Northern Ireland |
| Postcode | BT41 2RL |
| Country | Northern Ireland |
| ITL 1 | TLN Northern Ireland |
| ITL 2 | TLN0 Northern Ireland |
| ITL 3 | TLN0D Antrim and Newtownabbey |
| Local authority | Antrim and Newtownabbey |
| Electoral ward | Springfarm |
| Westminster constituency | South Antrim |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | NOVARTIS PHARMACEUTICALS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 3 Sep 2025 at 09:22 - Award - UK7 - Contract Details Notice - https://www.find-tender.service.gov.uk/Notice/053420-2025
- 7 Aug 2025 at 14:26 - Award - UK6 - Contract Award Notice - https://www.find-tender.service.gov.uk/Notice/046999-2025
- 26 Jun 2025 at 09:32 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/035302-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/053420-2025
  3rd September 2025 - Contract details notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/046999-2025
  7th August 2025 - Contract award notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/035302-2025
  26th June 2025 - Transparency notice on Find a Tender

## Notice URLs

- https://www.legislation.gov.uk/ukpga/2023/54/contents
- https://www.novartis.com/uk-en/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0553ef. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0553ef.json.